Pre-Open Stock Movers 02/17: (TUSK) (VSTM) (CSOD) Higher; (SHIP) (AFI) (KAR) Lower (more...) Feb 17, 2021 09:20AM
Verastem (VSTM) PT Lowered to $4 at Roth Capital May 14, 2019 08:11AM
Verastem (VSTM) PT Raised to $14 at Roth Capital Sep 25, 2018 10:37AM
Verastem (VSTM) PT Lowered to $10 at Roth Capital Jun 25, 2018 07:25AM
Pre-Open Movers 11/30: (SHLD) (SNPS) (ADMP) Higher; (BKS) (JNPR) (SMTC+) Lower (more...) Nov 30, 2017 09:14AM


Nov 30, 2017 07:18AM Roth Capital Starts Verastem (VSTM) at Buy
Sep 28, 2015 09:37AM Roth Capital Downgrades Verastem (VSTM) to Neutral
Aug 26, 2015 10:55AM Verastem (VSTM) Sell-Off 'Ignores Main Value Driver', Roth Capital Says
Jan 23, 2015 01:52PM Roth Capital Trims Verastem (VSTM) PT to $23 Followng Financing Activity
Jan 20, 2015 09:24AM Roth Capital Affirms Verastem (VSTM) at 'Buy'; VS-6063, VS-5584 Combo Study Initiated
Jan 9, 2015 09:24AM Verastem's (VSTM) Progress in COMMAND, Other Clinical Programs is 'Impressive' - Roth Capital
Oct 24, 2014 10:54AM Roth 'Encouraged' by Verastem's (VSTM) VS-6063 Effect on Biomarkers of CSCs
Jul 11, 2014 08:35AM Roth Affirms Verastem (VSTM) at 'Buy'; Encouraged by VS-6063's Potential in Mesothelioma, Ovarian Cancer
Mar 6, 2014 11:33AM Roth Keeps Verastem (VSTM) at Buy; Sees Positioned for 'Potentially Transformative Year'
Jul 17, 2013 09:25AM Verastem (VSTM) Prices $51.9M Common Stock Offering
Mar 13, 2013 07:19AM Roth Capital Starts Verastem (VSTM) at Buy